Olema Pharmaceuticals, Inc. and Aurigene Discovery Technologies Limited announced an exclusive global license agreement to research, develop and commercialize novel small molecule inhibitors of an undisclosed oncology target.
- Read more about Olema Oncology and Aurigene Announce Exclusive Collaboration and License Agreement to Discover and Develop Novel Cancer Therapies
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/olema-oncology-and-aurigene-announce-exclusive-collaboration-and-license-agreement-to-discover-and-develop-novel-cancer-therapies
No comments:
Post a Comment